Primary prevention of cardiovascular events in diabetes: is there a role for aspirin?

Journal article

The POPADAD (Prevention Of Progression of Arterial Disease And Diabetes) study did not show a benefit for low-dose aspirin therapy or administration of antioxidants for the primary prevention of cardiovascular disease events in individuals with diabetes and asymptomatic peripheral arterial disease. Although low-dose aspirin continues to be recommended in international guidelines, no convincing trial-based evidence exists that supports its routine use for primary prevention of cardiovascular d...

Expand abstract

Authors: Price, H; Holman, R

• Publication status: Published
• Journal: Nature clinical practice. Cardiovascular medicine
• Volume: 6
• Issue: 3
• Pages: 168-169
• Publication date: 2009-03-01
• DOI: 10.1038/ncpcardio1446
• EISSN: 1743-4300
• ISSN: 1743-4297
• Language: English
• Keywords: Primary Prevention; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Cardiovascular Diseases; Diabetes Mellitus; Aspirin; Diabetic Angiopathies; Humans; Antioxidants